NCT04839913View on ClinicalTrials.gov

Seroprevalence of SARS-CoV-2 in Unselected Surgical Patients: an Unicentric, Regional Study

CompletedOBSERVATIONAL
Enrollment

121

Participants

Timeline

Start Date

September 1, 2020

Primary Completion Date

December 10, 2020

Study Completion Date

January 10, 2021

Conditions
SARS-CoV InfectionSeroprevalenceCovid19
Interventions
DIAGNOSTIC_TEST

Antibodies testing

Serologic test for both SARS-COV-2 IgG and IgM

Trial Locations (1)

Unknown

University of Cagliari, Cagliari

All Listed Sponsors
lead

University of Cagliari

OTHER

NCT04839913 - Seroprevalence of SARS-CoV-2 in Unselected Surgical Patients: an Unicentric, Regional Study | Biotech Hunter | Biotech Hunter